Abstract: The present invention relates to contrast-enhanced radiographic imaging, the quantification of contrast agent in tissue and the assessment of the radiographic image quality. The invention provides a radiographic system-agnostic method to assess tissue administered with a radio-opaque contrast agent. The method is a system-agnostic means to accurately quantify contrast agent content in normal tissue and in cancerous tissue from contrast-enhanced radiographic images, and to assess and verify image quality and the efficacy of a clinical assessment from these images.
Type:
Application
Filed:
July 5, 2021
Publication date:
August 10, 2023
Applicants:
VOLPARA HEALTH TECHNOLOGIES LIMITED, VOLPARA SOLUTIONS EUROPE LIMITED